BackTaro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Receivables

Latest receivables for TARO: $180M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$177.46M
↓ 31.61% YoYΔ $-82.01M vs prior year quarter

Peer average

Loading

Taro Pharmaceutical Industries Receivables History

Loading

Taro Pharmaceutical Industries vs. peers: Receivables Comparison

Loading

Taro Pharmaceutical Industries Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Taro Pharmaceutical Industries (TARO) FAQ

Taro Pharmaceutical Industries (TARO) currently reports a receivables of $180M as of March 2024. That compares with $260M in the prior-year period — down 31.6% year over year. Use the charts on this page to explore Taro Pharmaceutical Industries's receivables history and peer comparisons.

Taro Pharmaceutical Industries's receivables decreased from $260M to $180M — a 31.6% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taro Pharmaceutical Industries reported $180M in receivables as of March 2024. That compares with $260M in the prior-year period — down 31.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taro Pharmaceutical Industries, and consider following TARO for alerts when major investors trade the stock.

Taro Pharmaceutical Industries is classified in the Healthcare sector. On receivables, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARO with unrelated industries.